Table 3. Associations between HULC expression and clinicopathological characteristics of the OS patients.
HULC expression | ||||||
---|---|---|---|---|---|---|
Low expression | High expression | |||||
N | % | N | % | p-value | ||
Age at diagnosis (years) | < 10 | 06 | 28.6 | 0 | 0.0 | 0.065 |
≥ 10 | 15 | 71.4 | 12 | 100.0 | ||
Gender | female | 11 | 52.4 | 06 | 50.0 | 0.999 |
male | 10 | 47.6 | 06 | 50.0 | ||
Tumor site | Femur | 06 | 28.6 | 06 | 50.0 | 0.274 |
Other | 15 | 71.4 | 06 | 50.0 | ||
Histological type | Osteoblastic | 13 | 68.4 | 11 | 91.7 | 0.201 |
Other | 06 | 31.6 | 01 | 8.3 | ||
Huvos grade | Grade 1/2 | 13 | 72.2 | 08 | 66.7 | 0.999 |
Grade 3/4 | 05 | 27.8 | 04 | 33.3 | ||
Tumor size (cm) | <12 | 07 | 58.3 | 04 | 44.4 | 0.670 |
≥12 | 05 | 41.7 | 05 | 55.6 | ||
Metastasis (during treatment) | no | 15 | 71.4 | 08 | 66.7 | 0.999 |
yes | 06 | 28.6 | 04 | 33.3 |